ALPS Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
5,081
+62
| +1% | +$3.41K | ﹤0.01% | 951 |
|
|
2025
Q1 | $355K | Sell |
5,019
-81
| -2% | -$5.73K | ﹤0.01% | 766 |
|
|
2024
Q4 | $335K | Hold |
5,100
| – | – | ﹤0.01% | 824 |
|
|
2024
Q3 | $358K | Buy |
+5,100
| New | +$358K | ﹤0.01% | 828 |
|
|
2022
Q1 | – | Sell |
-4,830
| Closed | -$427K | – | 842 |
|
|
2021
Q4 | $427K | Buy |
4,830
+58
| +1% | +$5.13K | ﹤0.01% | 596 |
|
|
2021
Q3 | $369K | Buy |
+4,772
| New | +$369K | ﹤0.01% | 646 |
|
|
2020
Q3 | – | Sell |
-2,618
| Closed | -$323K | – | 828 |
|
|
2020
Q2 | $323K | Sell |
2,618
-289
| -10% | -$35.7K | ﹤0.01% | 535 |
|
|
2020
Q1 | $246K | Buy |
+2,907
| New | +$246K | ﹤0.01% | 579 |
|